Overestimation of Oxygen Saturation Leads to Delayed COVID-19 Treatment
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, Aug. 31, 2023 -- Overestimation of oxygen saturation by pulse oximetry leads to delayed delivery of COVID-19 therapy, according to a study published online Aug. 24 in JAMA Network Open.
Ashraf Fawzy, M.D., M.P.H., from Johns Hopkins University School of Medicine in Baltimore, and colleagues examined the effect of overestimation of oxygen saturation by pulse oximetry in a cohort study including patients hospitalized for COVID-19 at 186 U.S. acute care facilities with at least one functional arterial oxygen saturation (SaO2) measurement. A subset of patients were admitted without immediate need for COVID-19 therapy based on pulse oximeter saturation (SpO2 levels of 94 percent or higher without supplemental oxygen). A total of 24,504 patients had concurrent SpO2 and SaO2 measurements.
The researchers found that pulse oximetry overestimated SaO2 for Black, Hispanic, and other patients versus White patients (adjusted mean differences, 0.93, 0.49, and 0.53 percentage points, respectively). In a subset of 8,635 patients with a concurrent SpO2-SaO2 pair without immediate need for COVID-19 therapy, Black patients were more likely than White patients to have pulse oximetry values that masked an indication for COVID-19 therapy (adjusted odds ratio [aOR], 1.65; 95 percent confidence interval [CI], 1.33 to 2.03). The likelihood of receiving COVID-19 therapy was lower for patients with an unrecognized need for COVID-19 therapy (aOR, 0.90; 95 percent CI, 0.83 to 0.97), and these patients had higher odds of readmission, regardless of race (aOR, 2.41; 95 percent CI, 1.39 to 4.18). Unrecognized need for COVID-19 therapy was not associated with in-hospital mortality or length of stay.
"Improved accuracy of pulse oximeters, which play an important role in triage and treatment decisions, is critical to delivery of timely and equitable care to patients with COVID-19," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Further Support and Information on COVID-19
Read this next
First Responders With More Debris Exposure Have Higher Risk of Early Dementia
FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...
1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...
Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy
FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.